← Back to Search

PENG Block vs. Local Anesthetic for Hip Replacement Anesthesia

N/A
Recruiting
Led By Shalini Dhir, FRCPC
Research Sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing THA with a direct lateral surgical approach (transgluteal approach)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-24 hours following completion of spinal anesthesia

Summary

This trial will study a new technique called the pericapsular nerve group (PENG) block for patients undergoing hip replacement surgery. The current standard treatment involves injecting a mix of local anesthetic,

Who is the study for?
This trial is for adults over 18 years old who are having a total hip arthroplasty (hip replacement surgery) using a specific surgical approach. Participants must be able to give consent. It's not suitable for those with conditions that rule out the use of local anesthetics or nerve blocks.
What is being tested?
The study compares two pain management methods in hip surgery: PENG block, which numbs certain nerves, and the standard care involving local anesthetic infiltration possibly mixed with morphine and NSAIDs. The goal is to see if PENG can match or exceed current methods in pain relief and cost-effectiveness.
What are the potential side effects?
Potential side effects may include discomfort at the injection site, numbness beyond the targeted area, allergic reactions to medications used, and less commonly nerve damage or infection from the procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am having a hip replacement through a side (lateral) approach.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-24 hours following completion of spinal anesthesia
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-24 hours following completion of spinal anesthesia for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PENG block impact on post-operative pain scores
Secondary study objectives
PENG block impact on quadriceps muscle strength post-operatively
Patient opioid consumption 24 hours period after spinal anesthesia procedure.
Time spent in post-anesthesia care unit (PACU) following surgery

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PENG BlockExperimental Treatment1 Intervention
Participants will receive ultrasound-guided PENG block (PENG group) with local anesthetics (20 ml of 0.5% ropivacaine) before administration of spinal anesthesia.
Group II: Control GroupPlacebo Group1 Intervention
Participants will receive a sham PENG block performed with 20ml of normal saline solution before spinal anesthesia. After, patients will receive ILAI (performed by the operating surgeon) with a plain solution of ropivacaine 0.25% 60ml.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PENG Block
2022
Completed Phase 3
~400

Find a Location

Who is running the clinical trial?

London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph'sLead Sponsor
572 Previous Clinical Trials
401,385 Total Patients Enrolled
Lawson Health Research InstituteLead Sponsor
683 Previous Clinical Trials
431,280 Total Patients Enrolled
Shalini Dhir, FRCPCPrincipal InvestigatorWestern University
6 Previous Clinical Trials
724 Total Patients Enrolled
~93 spots leftby Jun 2026